Navigation Links
Gene Can Dampen Chemo Drug Effectiveness
Date:6/10/2009

Alternatives to current breast cancer therapy needed for some patients, study says

WEDNESDAY, June 10 (HealthDay News) -- Women with a certain type of gene may show marked resistance to an important chemotherapy drug used to treat breast cancer, new research suggests.

Scientists at the U.S. National Cancer Institute (NCI) suspect that the variation in the SOD2 gene affects how a patient responds to cyclophosphamide, an agent used against breast tumors, blood cancers and other malignancies. The research is the first to show a mechanism and a biomarker for cyclophosphamide resistance.

Although this is not good news for some patients, the findings have a silver lining: New tests may soon be developed to help doctors screen for genetic markers and create "tailored" therapies, according to an NCI news release.

"In the future, such tests may be used to guide the treatment of patients with the SOD2 variation, ensuring that they receive a therapy that is more effective than cyclophosphamide-based therapy," senior study author Stefan Ambs, of the NCI's Center for Cancer Research, said in the news release.

The study, published online June 9 in Clinical Cancer Research, looked at 588 breast cancer patients in Norway and the United States. Those who had the variation experienced poorer survival on the drug, the researchers found. Scientists believe that the SOD2 variant interferes with the structure and function of an important cellular protein.

More information

The American Cancer Society offers more information on breast cancer.



-- Peter West



SOURCE: U.S. National Cancer Institute, news release, June 9, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Fallout From Failed AIDS Vaccine Could Dampen Research
2. Drinking Dampens Ability to Feel Fear
3. Autoimmune Disease Treatment May Not Dampen Immune System
4. Economy Doesnt Dampen Colorados Giving Spirit According to Statewide Giving and Volunteering Study
5. Experimental Drug May Dampen Severe Asthma
6. Obesity May Dampen Response to Asthma Meds
7. Chemotherapy may be culprit for fatigue in breast cancer survivors
8. Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
9. To evade chemotherapy, some cancer cells mimic stem cells
10. New chemotherapy regimen prolongs survival in difficult-to-treat childhood brainstem gliomas
11. PET scans can accurately detect a breast tumors response to chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene Can Dampen Chemo Drug Effectiveness 
(Date:2/24/2017)... ... 2017 , ... The International Association of Eating Disorders Professionals (iaedp) announces the ... body image mannequin art competition. Selected from 15 submissions from around the nation, the ... the 31st annual iaedp Symposium, March 22 – 26 in Las Vegas. , This ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... The ... for excellence in radiology marketing programs at the annual Building Better Radiology Marketing ... Renaissance Fort Worth Hotel in Fort Worth, Texas. Nine awards are given out in ...
(Date:2/24/2017)... Emeryville, CA (PRWEB) , ... February 24, 2017 ... ... Esparza for qualifying into the Senior International Elite division on February 12th. ... All Around divisions at the elite qualifier competition held in Las Vegas, Nevada. ...
(Date:2/23/2017)... TX (PRWEB) , ... February 23, 2017 , ... ... announced an official 2017 partnership with The Jensie Gran Fondo of Marin. For ... and UVB rays with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... The 89th ... the winner of the 2016 National Education Policy Center Bunkum Award. We invite you ... in 2016. , This year’s Bunkum winner is the Center for American Progress (CAP), ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Feb 23, 2017 Research and Markets has ... and Strategies - 2016" report to their offering. ... The latest research Oesophageal ... data and benchmarks in the global Oesophageal Cancer market. ... What are the key drugs marketed for Oesophageal Cancer and their ...
(Date:2/23/2017)... CITY, Calif. , Feb. 23, 2017 /PRNewswire/ ... pharmaceutical company focused on the development and commercialization ... acute pain, announced that it will release fourth ... on Thursday, March 2nd, 2017. AcelRx management will ... Eastern Time (1:30 p.m. Pacific Time) on March ...
(Date:2/23/2017)... 2017 Obese people are seldom ... varicose veins in their body. The rising number of ... adoption of endovenous laser therapy for treatment of varicose ... therapy market, published by Future Market Insights, indicates ... consequences of obesity have collectively factored the growth in ...
Breaking Medicine Technology: